返回 
加入收藏
胃癌药物治疗专家共识
x
请在关注微信后，向客服人员索取文件
| 篇名： | 胃癌药物治疗专家共识 |
| TITLE： | Expert consensus on drug therapy for gastric cancer |
| 摘要： | 目的 指导胃癌（GC）的临床治疗用药，提高患者生存率，改善患者生存质量，为临床医师治疗决策提供参考。方法由重庆大学附属肿瘤医院肿瘤内科专家组成员采用名义群体法共同讨论确定《胃癌药物治疗专家共识》编写大纲。编写组专家针对大纲涉及内容进行系统检索、分析、归纳及总结，并根据我国现状、临床需求和研究证据初步拟定推荐建议。重庆市医学肿瘤学分会化疗学组及重庆市医药生物技术协会肿瘤罕见病疑难病专委会专家经过多轮会议讨论，对推荐建议进行修订，以投票形式确定最终共识内容和推荐等级。结果与结论本共识内容包括胃癌的围手术期药物治疗、晚期转移性胃癌一线药物治疗、晚期转移性胃癌二线药物治疗、晚期胃癌三线及三线以上药物治疗、胃癌腹膜转移的药物治疗。本共识的发布为我国医疗机构在胃癌的个体化用药方面提供了规范化管理的建议，对提高胃癌的临床疗效、用药安全具有重要意义。 |
| ABSTRACT： | OBJECTIVE To guide the clinical medication of gastric cancer， enhance patients’ survival rates， improve patients’ quality of life， and provide a reference for clinicians in making treatment decisions. METHODS The nominal group method was employed， wherein members of the expert group from the Department of Oncology at Chongqing University Cancer Hospital collaboratively discussed and established the outline for the preparation of the Expert Consensus on Drug Treatment of Gastric Cancer. The writing team of experts systematically searched， analyzed， and summarized the relevant content outlined， as well as formulated consensus statements based on the current situation in China， clinical needs， and research evidence. After multiple rounds of meetings and discussions， the experts from the Chemotherapy Group of the Chongqing Medical Oncology Branch and the Special Committee on Rare and Difficult Cancers of Chongqing Medical and Biotechnology Association revised the recommendation and ultimately reached the consensus content and recommendation level through voting. RESULTS & CONCLUSIONS This consensus encompasses perioperative drug therapy for gastric cancer， first-line drug therapy for advanced metastatic gastric cancer， second-line drug therapy for advanced metastatic gastric cancer， third-line and subsequent drug therapies for advanced gastric cancer， and drug therapy for peritoneal metastasis of gastric cancer. The release of this consensus offers standardized management suggestions for the individualized medication of gastric cancer by medical institutions in China， which is of great significance for enhancing the clinical efficacy and medication safety associated with gastric cancer treatment. |
| 期刊： | 2025年第36卷第03期 |
| 作者： | 重庆市医学会肿瘤学分会化疗学组；重庆市医药生物技术协会肿瘤罕见病疑难病专委会 |
| AUTHORS： | Chemotherapy Group of the Chongqing Medical Oncology Branch，Special Committee on Rare and Difficult Cancers of Chongqing Medicinal Biotech Association |
| 关键字： | 胃癌；抗肿瘤药物；化疗；免疫治疗；靶向治疗；手术；专家共识 |
| KEYWORDS： | gastric cancer； anti-tumor drug； chemotherapy； immunotherapy； targeted therapy； surgical operation； expert |
| 阅读数： | 3 次 |
| 本月下载数： | 0 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
